Skip to content
value.today

Adarza BioSystems, Inc.

Formerly Pathologics Associates, Inc.

Total raised
$31 M
4 rounds on record
Latest round
$13 M
Nov 2019
First round on record
Jun 2014
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Adarza BioSystems, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2019$13 MNo. 4$10 to $50 million

Adarza BioSystems, Inc.: Raise no. 4, Nov 2019

Investors in this round

7 investors had bought by the notice of Feb 6, 2020: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $27 M offered; $14 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bryan Witherbee · Executive Officer, Director
  • Benjamin Miller · Director
  • David Smoller · Director
  • Jay Schmelter · Director
  • Jenny Rooke · Director
  • John Mckearn · Director
  • Larry Page · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bryan Witherbee, President. Source: SEC Form D, newest notice filed Feb 6, 2020. Read the notice at the SEC.

equitySEC
Jan 2017$11 MNo. 3$10 to $50 million

Adarza BioSystems, Inc.: Raise no. 3, Jan 2017

Investors in this round

16 investors had bought by the notice of Jan 16, 2018: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $17 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bryan Witherbee · Executive Officer, Director
  • Linda Meeh · Executive Officer
  • Benjamin Miller · Director
  • David Smoller · Director
  • Jay Schmelter · Director
  • Jenny Rooke · Director
  • John McKearn, Ph.D. · Director
  • Scott Bernstein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bryan Witherbee, President. Source: SEC Form D and 1 amendment, newest notice filed Jan 16, 2018. Read the notice at the SEC.

equitySEC
Mar 2016$5 MNo. 2$2 to $10 million

Adarza BioSystems, Inc.: Raise no. 2, Mar 2016

Investors in this round

19 investors had bought by the notice of Mar 28, 2016: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $7 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher R. Striemer · Executive Officer
  • Randolph R. Henke · Executive Officer, Director, Promoter
  • Andrew R. Jay · Director
  • Benjamin R. Miller · Director
  • David R. Smoller · Director
  • Heiner R. Dreismann · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Randolph Henke, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 28, 2016. Read the notice at the SEC.

equitySEC
Jun 2014$2 MNo. 1$2 to $10 million

Adarza BioSystems, Inc.: Raise no. 1, Jun 2014

Investors in this round

13 investors had bought by the notice of Jul 3, 2014: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher R. Striemer · Executive Officer
  • Randolph R. Henke · Executive Officer, Director, Promoter
  • Teryl R. Gronwall · Executive Officer
  • Benjamin R. Miller · Director
  • David R. Smoller · Director
  • Heiner R. Dreismann · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Teryl Gronwall, Chief Operating Officer. Source: SEC Form D, newest notice filed Jul 3, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Adarza BioSystems, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2020).

    SEC Form D · Feb 2020

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Feb 2020

That is all the official record says: Adarza BioSystems, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Adarza BioSystems, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Adarza BioSystems, Inc.
NameRoleNamed in
Bryan WitherbeeExecutive officerFeb 2020
Linda MeehExecutive officerJan 2018
Christopher StriemerExecutive officerJan 2017
Christopher R. StriemerExecutive officerMar 2016
Randolph R. HenkeExecutive officerMar 2016
Teryl R. GronwallExecutive officerJul 2014
Benjamin MillerDirectorFeb 2020
Bryan WitherbeeDirectorFeb 2020
David SmollerDirectorFeb 2020
Jay SchmelterDirectorFeb 2020
Jenny RookeDirectorFeb 2020
John MckearnDirectorFeb 2020
Larry PageDirectorFeb 2020
John McKearn, Ph.D.DirectorJan 2018
Scott BernsteinDirectorJan 2018
Andrew JayDirectorJan 2017
Brian R. HopcraftDirectorJan 2017
Jay R. SchmelterDirectorJan 2017
John R. McKearn, Ph.D.DirectorJan 2017
Andrew R. JayDirectorMar 2016
Benjamin R. MillerDirectorMar 2016
David R. SmollerDirectorMar 2016
Heiner R. DreismannDirectorMar 2016
Randolph R. HenkeDirectorMar 2016
Randolph R. HenkePromoterJan 2017